A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial …
JM Hare, JH Traverse, TD Henry, N Dib… - Journal of the American …, 2009 - jacc.org
Objectives: Our aim was to investigate the safety and efficacy of intravenous allogeneic
human mesenchymal stem cells (hMSCs) in patients with myocardial infarction (MI) …
human mesenchymal stem cells (hMSCs) in patients with myocardial infarction (MI) …
Bone marrow-derived cells for cardiac repair
RO Cannon III - Cytotherapy, 2009 - Taylor & Francis
978 RO Cannon the left ventricular ejection fraction by cardiac magnetic resonance imaging
(MRI), findings not observed in placebotreated animals over 3 months. Multicenter …
(MRI), findings not observed in placebotreated animals over 3 months. Multicenter …
Cellules stromales mésenchymateuses et vecteurs polymériques pour l'ingénierie tissulaire du système nerveux central
GJR Delcroix - 2009 - theses.hal.science
Les cellules stromales mésenchymateuses (CSM) possèdent de nombreux atouts pour la
thérapie cellulaire du cerveau. Nous avons tout d'abord démontré que les CSM ne migraient …
thérapie cellulaire du cerveau. Nous avons tout d'abord démontré que les CSM ne migraient …
Lokalisationsdiagnostik markierter Stammzellen mittels Fluoreszenzangiographie am Schweineherz in vivo
MVV Stubbendorff - 2009 - elib.tiho-hannover.de
The application of mesenchymal stem cells is a newly used therapy for patients suffering
from ischemic myocardial injury. Stem cell therapy after myocardial infarction gives new …
from ischemic myocardial injury. Stem cell therapy after myocardial infarction gives new …